公开(公告)号：JP2013102687A

公开(公告)日：2013-05-23

申请号：JP2013014318

申请日：2013-01-29

Applicant: Krishnan Ramu ,  クリシュナン ラム ,  Cheewoo Lee ,  チェーウー リー ,  Nimal Savio Lobo ,  ニーマル サヴィオ ロボ

Inventor： RAMU KRISHNAN ,  LEE CHEEWOO ,  LOBO NIMAL SAVIO

IPC: H02K19/10 ,  H02K1/14

CPC classification number: H02K1/14 ,  H02K19/106

Abstract: PROBLEM TO BE SOLVED: To minimize the dimension of a stator iron core.SOLUTION: The switched reluctance device includes a rotor 112 having a plurality of rotor magnetic poles 114, and a first stator structure 100 and a second stator structure 102 which have conductivity of magnetic flux transmission. The first stator structure 100 has a first stator magnetic pole 106, a second stator magnetic pole 108 and a third stator magnetic pole 110 which are connected to each other by a first stator back portion 104, and the second stator structure 102 is the same as the first stator structure 100. The first stator back portion 104 and the second stator back portion 104 are separated from each other by a medium having no conductivity of direct magnetic flux transmission. The rotor magnetic poles are divided into any one or two rotor magnetic poles in accordance with rotation of the rotor 112, and are rotated in accordance with the rotor 112 while extending in a radial direction from a fixing position on a rotation axis. Virtual geometric magnetic flux lines sequentially traverse each of the stator magnetic poles of the first stator structure 100 and the second stator structure 102.

Abstract translation: 要解决的问题：使定子铁芯的尺寸最小化。 解决方案：开关磁阻器件包括具有多个转子磁极114的转子112和具有磁通传输的导电性的第一定子结构100和第二定子结构102。 第一定子结构100具有第一定子磁极106，第二定子磁极108和第三定子磁极110，第一定子磁极106和第三定子磁极110通过第一定子后部104彼此连接，第二定子结构102与 第一定子结构100.第一定子背部104和第二定子背部104通过不具有直接磁通传输的导电性的介质彼此分离。 转子磁极根据转子112的旋转被分成任何一个或两个转子磁极，并且在从旋转轴线的固定位置沿径向方向延伸的同时根据转子112旋转。 虚拟几何磁通线顺序地穿过第一定子结构100和第二定子结构102的每个定子磁极。版权所有：（C）2013，JPO＆INPIT

公开(公告)号：EP1898922A4

公开(公告)日：2012-03-14

申请号：EP06766275

申请日：2006-06-29

Applicant: KRISHNAN RAMU

Inventor： KRISHNAN RAMU

IPC: A61K31/56 ,  A61K9/00 ,  A61K31/397 ,  A61K31/40 ,  A61K31/47 ,  A61K31/505 ,  A61P3/06 ,  C07J5/00

CPC classification number: A61K31/426 ,  A61K9/0014 ,  A61K9/0053 ,  A61K47/186

公开(公告)号：CA2613875C

公开(公告)日：2018-09-25

申请号：CA2613875

申请日：2006-06-29

Applicant: KRISHNAN RAMU

Inventor： KRISHNAN RAMU

IPC: A61K31/56 ,  C07J5/00

Abstract: The administration of pharmaceuticals of drugs which are having less solubility, lower bioavailability, lower bioabsorbability, less rte of absorption has become a big challenge in day today life. Therefore anattempt has been made to prepare a complex modified form of the said pharmaceutical or drug such that the modified complex drugs or pharmaceuticals exhibits the enhanced properties of solubility, bioavailability, bioabsorbability and rate of absorption despite the increased complexity of the molecule. Surprisingly such modification was found to enhance retentivity of the active drug ingredient in the blood. Higher amounts of the active drug ingredient has shown lower toxicity.

公开(公告)号：EP1898922A2

公开(公告)日：2008-03-19

申请号：EP06766275.9

申请日：2006-06-29

Applicant: Krishnan, Ramu

Inventor： Krishnan, Ramu

IPC: A61K31/56 ,  C07J5/00

CPC classification number: A61K31/426 ,  A61K9/0014 ,  A61K9/0053 ,  A61K47/186

Abstract: The administration of pharmaceuticals of drugs which are having less solubility, lower bioavailability, lower bioabsorbability, less rte of absorption has become a big challenge in day today life. Therefore anattempt has been made to prepare a complex modified form of the said pharmaceutical or drug such that the modified complex drugs or pharmaceuticals exhibits the enhanced properties of solubility, bioavailability, bioabsorbability and rate of absorption despite the increased complexity of the molecule. Surprisingly such modification was found to enhance retentivity of the active drug ingredient in the blood. Higher amounts of the active drug ingredient has shown lower toxicity.

公开(公告)号：CA2613875A1

公开(公告)日：2007-01-11

申请号：CA2613875

申请日：2006-06-29

Applicant: KRISHNAN RAMU

Inventor： KRISHNAN RAMU

IPC: A61K31/56 ,  C07J5/00

Abstract: The administration of pharmaceuticals of drugs which are having less solubility, lower bioavailability, lower bioabsorbability, less rate of absorption has become a big challenge in day to day life. Therefore an attempt has been made to prepare a complex modified form of the said pharmaceutical or drug such that the modified complex drugs or pharmaceuticals exhibits the enhanced properties of solubility, bioavailability, bioabsorbability and rate of absorption despite the increased complexity of the molecule. Surprisingly such modification was found to enhance retentivity of the active drug ingredient in the blood. Higher amounts of the active drug ingredient has shown lower toxicity.

公开(公告)号：AU2006264407B2

公开(公告)日：2012-08-30

申请号：AU2006264407

申请日：2006-06-29

Applicant: KRISHNAN RAMU

Inventor： KRISHNAN RAMU

IPC: A61K31/56 ,  C07J5/00

Abstract: The administration of pharmaceuticals of drugs which are having less solubility, lower bioavailability, lower bioabsorbability, less rte of absorption has become a big challenge in day today life. Therefore anattempt has been made to prepare a complex modified form of the said pharmaceutical or drug such that the modified complex drugs or pharmaceuticals exhibits the enhanced properties of solubility, bioavailability, bioabsorbability and rate of absorption despite the increased complexity of the molecule. Surprisingly such modification was found to enhance retentivity of the active drug ingredient in the blood. Higher amounts of the active drug ingredient has shown lower toxicity.

公开(公告)号：AU2006264407A1

公开(公告)日：2007-01-11

申请号：AU2006264407

申请日：2006-06-29

Applicant: KRISHNAN RAMU

Inventor： KRISHNAN RAMU

IPC: A61K31/56 ,  C07J5/00

Abstract: The administration of pharmaceuticals of drugs which are having less solubility, lower bioavailability, lower bioabsorbability, less rate of absorption has become a big challenge in day to day life. Therefore an attempt has been made to prepare a complex modified form of the said pharmaceutical or drug such that the modified complex drugs or pharmaceuticals exhibits the enhanced properties of solubility, bioavailability, bioabsorbability and rate of absorption despite the increased complexity of the molecule. Surprisingly such modification was found to enhance retentivity of the active drug ingredient in the blood. Higher amounts of the active drug ingredient has shown lower toxicity.

公开(公告)号：WO2022175962A1

公开(公告)日：2022-08-25

申请号：PCT/IN2021/050154

申请日：2021-02-18

Applicant: KRISHNAN, Ramu

Inventor： KRISHNAN, Ramu

IPC: A61L9/015 ,  A61L2/18

Abstract: The present invention is related to make the surroundings hygiene by killing or inactivating most of the microorganisms that are suspending in the air. Species or type of microorganism is immaterial to work the present invention.

公开(公告)号：WO2007004236A3

公开(公告)日：2007-01-11

申请号：PCT/IN2006/000222

申请日：2006-06-29

Applicant: KRISHNAN, Ramu

Inventor： KRISHNAN, Ramu

IPC: A61K31/56 ,  C07J5/00

Abstract: The administration of pharmaceuticals of drugs which are having less solubility, lower bioavailability, lower bioabsorbability, less rte of absorption has become a big challenge in day today life. Therefore anattempt has been made to prepare a complex modified form of the said pharmaceutical or drug such that the modified complex drugs or pharmaceuticals exhibits the enhanced properties of solubility, bioavailability, bioabsorbability and rate of absorption despite the increased complexity of the molecule. Surprisingly such modification was found to enhance retentivity of the active drug ingredient in the blood. Higher amounts of the active drug ingredient has shown lower toxicity.

公开(公告)号：WO2004082592A3

公开(公告)日：2004-12-16

申请号：PCT/IN2004000063

申请日：2004-03-17

Applicant: KRISHNAN RAMU

Inventor： KRISHNAN RAMU

IPC: A23L1/30 ,  A61K20060101 ,  C07C229/76

CPC classification number: C07C229/76 ,  A23L33/17

Abstract: The present invention relates to compositions and methods for preparing Metal Amino Acid Chelates having a nutritionally relevant Anion Radical(s) having higher solubility and better bio absorption. The composition is prepared by reacting a metal Amino Acid Hydroxide Chelate with a nutritionally relevant acid radical in a suitable mole ratio such that the new chelate formed has the metal Amino Acid Structure unchanged but is bonded forming quarternary ammonium ion(s) to a nutritionally Relevant Anion Radical(s) obtained by ionic dissociation of a nutritionally Relevant acid(s).

Abstract translation: 本发明涉及用于制备具有较高溶解度和较好生物吸收的营养相关阴离子自由基的金属氨基酸螯合物的组合物和方法。 该组合物通过使金属氨基酸氢氧化物螯合物与营养相关酸基以合适的摩尔比反应来制备，使得所形成的新螯合物具有未改变的金属氨基酸结构但键合形成季铵离子到营养相关物 通过离子解离营养相关酸获得的阴离子自由基。